Pricing Turning Point: The Case for Innovating Pharma’s Model
Published: | Updated:
Drawing from implementation lessons and successes in other industries, possible strategy shifts to pharma’s pricing playbook are explored.
Juan F. Rivera
Advertisement
Articles by Juan F. Rivera
Advertisement
Latest Updated Articles
Pricing Turning Point: The Case for Innovating Pharma’s ModelPublished: March 6th 2018 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
5